{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:12Z","timestamp":1790798652112,"version":"4.1.0"},"reference-count":51,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004073","name":"Killam Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004073","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023921","name":"Structural Genomics Consortium","doi-asserted-by":"publisher","award":["1097737"],"award-info":[{"award-number":["1097737"]}],"id":[{"id":"10.13039\/501100023921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI171292-01"],"award-info":[{"award-number":["1U19AI171292-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM122481"],"award-info":[{"award-number":["R35GM122481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transmembrane protease serine-2 (TMPRSS2) is an essential host entry factor in human airways for SARS-CoV-2 and influenza A\/B and has presented as a target for antiviral drug development; however, no clinically viable oral small-molecule TMPRSS2 inhibitors have been developed to date. Here, we perform two large-scale docking campaigns to identify covalent and noncovalent TMPRSS2 small-molecule inhibitors using a homology model and crystal structure. We establish a pipeline to rapidly screen TMPRSS2 inhibitors and then interrogate the potency, selectivity, and biophysical properties of covalent and noncovalent inhibition using enzyme kinetics on synthetic peptide and protein substrates and differential scanning fluorimetry. Furthermore, we established a readily crystallizable form of TMPRSS2 protein that produced high-resolution crystal structures with nafamostat, \u2018157, and 6-amidino-2-naphthol. A novel noncovalent inhibitor scaffold is biochemically validated as a potential avenue for developing TMPRSS2-selective inhibitors.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.4c03089","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:27:44Z","timestamp":1758324464000},"page":"19893-19907","source":"Crossref","is-referenced-by-count":5,"title":["Large Library\nDocking and Biophysical Analysis of\nSmall-Molecule TMPRSS2 Inhibitors"],"prefix":"10.1021","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-106X","authenticated-orcid":true,"given":"Bryan J.","family":"Fraser","sequence":"first","affiliation":[{"name":"Structural Genomics Consortium Toronto , , ,","place":["Toronto, Ontario, Canada, M5G 1L7"]},{"name":"University of Toronto , , , ,","place":["Toronto, Ontario, Canada, M5G 2C4"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Young","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-9480","authenticated-orcid":true,"given":"Brian J.","family":"Bender","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gahbauer","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olzhas","family":"Ilyassov","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium Toronto , , ,","place":["Toronto, Ontario, Canada, M5G 1L7"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium Toronto , , ,","place":["Toronto, Ontario, Canada, M5G 1L7"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Li","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium Toronto , , ,","place":["Toronto, Ontario, Canada, M5G 1L7"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almagul","family":"Seitova","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium Toronto , , ,","place":["Toronto, Ontario, Canada, M5G 1L7"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre\u0301 Luiz","family":"Lourenc\u0327o","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hee","family":"Chung","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conner","family":"Bardine","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7995-3581","authenticated-orcid":true,"given":"Franc\u0327ois","family":"Be\u0301nard","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Research Institute , , ,","place":["Vancouver, British Columbia, Canada, V5Z 0B4"]},{"name":"University of British Columbia , , , ,","place":["Vancouver, British Columbia, Canada, V6T 2B5"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-7367","authenticated-orcid":true,"given":"Brian K.","family":"Shoichet","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-9185","authenticated-orcid":true,"given":"Charles S.","family":"Craik","sequence":"additional","affiliation":[{"name":"University of California , , , ,","place":["San Francisco, California, United States, 94158"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-3250","authenticated-orcid":true,"given":"Cheryl H.","family":"Arrowsmith","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium Toronto , , ,","place":["Toronto, Ontario, Canada, M5G 1L7"]},{"name":"University of Toronto , , , ,","place":["Toronto, Ontario, Canada, M5G 2C4"]},{"name":"Princess Margaret Cancer Research Centre , , ,","place":["Toronto, Ontario, Canada, M5G 2C4"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"8","key":"2026093015122681500_cit1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4712","article-title":"Large library docking for novel SARS-CoV-2 main protease\nnon-covalent and covalent inhibitors","volume":"32","author":"Fink","year":"2023","journal-title":"Protein\nSci."},{"key":"2026093015122681500_cit2","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M\npro inhibitor clinical candidate for the treatment\nof COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"2026093015122681500_cit3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry\nDepends on ACE2 and TMPRSS2 and Is Blocked\nby a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2026093015122681500_cit4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2\nentry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026093015122681500_cit5","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and furin are\nboth essential for proteolytic activation of\nSARS-CoV-2 in human airway cells","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci.\nAlliance"},{"key":"2026093015122681500_cit6","doi-asserted-by":"publisher","first-page":"100135","DOI":"10.1074\/jbc.REV120.015980","article-title":"Priming of\nSARS-CoV-2 S protein by several membrane-bound serine proteinases\ncould explain enhanced viral infectivity and systemic COVID-19 infection","volume":"296","author":"Fuentes-Prior","year":"2021","journal-title":"J. Biol. Chem."},{"key":"2026093015122681500_cit7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejcb.2015.05.013","article-title":"Influenza virus activating\nhost proteases: Identification, localization\nand inhibitors as potential therapeutics","volume":"94","author":"Garten","year":"2015","journal-title":"Eur.\nJ. Cell Biol."},{"key":"2026093015122681500_cit8","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome\nCoronavirus Spike Protein for Membrane Fusion and Reduces Viral Control\nby the Humoral Immune Response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"issue":"4","key":"2026093015122681500_cit9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009500","article-title":"The SARS-CoV-2 and other\nhuman coronavirus spike proteins are fine-tuned towards temperature\nand proteases of the human airways","volume":"17","author":"Laporte","year":"2021","journal-title":"PLoS Pathog"},{"key":"2026093015122681500_cit10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor\nacts as a pan-SARS-CoV-2 prophylactic and therapeutic","volume":"605","author":"Shapira","year":"2022","journal-title":"Nature"},{"key":"2026093015122681500_cit11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fmolb.2020.00215","article-title":"COVID-19:\nTargeting Proteases in\nViral Invasion and Host Immune Response","volume":"7","author":"Seth","year":"2020","journal-title":"Front.\nMol. Biosci."},{"key":"2026093015122681500_cit12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fmolb.2021.725528","article-title":"Host Serine Proteases: A Potential Targeted Therapy\nfor COVID-19 and Influenza","volume":"8","author":"Rahbar Saadat","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"2026093015122681500_cit13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1126\/science.1157121","article-title":"The serine protease TMPRSS6 is required to sense iron\ndeficiency","volume":"320","author":"Du","year":"2008","journal-title":"Science"},{"issue":"10","key":"2026093015122681500_cit14","doi-asserted-by":"publisher","first-page":"105238","DOI":"10.1016\/j.jbc.2023.105238","article-title":"Matriptase-2\nregulates iron homeostasis primarily by setting the basal levels of\nhepatic hepcidin expression through a nonproteolytic mechanism","volume":"299","author":"Enns","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"15","key":"2026093015122681500_cit15","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.1073\/pnas.150149097","article-title":"Corin, a transmembrane cardiac serine\nprotease, acts as a pro-atrial natriuretic peptide-converting enzyme","volume":"97","author":"Yan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026093015122681500_cit16","doi-asserted-by":"publisher","first-page":"3192090","DOI":"10.1155\/2017\/3192090","article-title":"Identification of TMPRSS3 as a Significant Contributor to Autosomal\nRecessive Hearing Loss in the Chinese Population","volume":"2017","author":"Gao","year":"2017","journal-title":"Neural Plast"},{"key":"2026093015122681500_cit17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.stemcr.2019.05.014","article-title":"Defective Tmprss3-Associated\nHair Cell Degeneration in Inner Ear\nOrganoids","volume":"13","author":"Tang","year":"2019","journal-title":"Stem Cell Rep."},{"key":"2026093015122681500_cit18","doi-asserted-by":"publisher","first-page":"17383","DOI":"10.1074\/jbc.M110.190652","article-title":"TMPRSS3, a transmembrane\nserine protease deficient in human DFNB8\/10\ndeafness, is critical for cochlear hair cell survival at the onset\nof hearing","volume":"286","author":"Fasquelle","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2026093015122681500_cit19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/adc.45.243.651","article-title":"Intestinal Enterokinase\nDeficiency A Newly-recognized Disorder of Protein Digestion","volume":"45","author":"Tarlow","year":"1970","journal-title":"Arch. Dis. Child."},{"key":"2026093015122681500_cit20","doi-asserted-by":"publisher","first-page":"12812","DOI":"10.18632\/oncotarget.14559","article-title":"High TMPRSS11D protein expression predicts poor overall survival\nin non-small cell lung cancer","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"2026093015122681500_cit21","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1038\/ncomms7776","article-title":"Targeting matriptase\nin breast cancer abrogates tumour progression\nvia impairment of stromal-epithelial growth factor signalling","volume":"6","author":"Zoratti","year":"2015","journal-title":"Nat. Commun."},{"key":"2026093015122681500_cit22","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1038\/sj.onc.1210914","article-title":"TMPRSS4 promotes invasion,\nmigration and metastasis of human tumor\ncells by facilitating an epithelial-mesenchymal transition","volume":"27","author":"Jung","year":"2008","journal-title":"Oncogene"},{"key":"2026093015122681500_cit23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccr.2004.07.008","article-title":"Hepsin promotes prostate cancer progression and metastasis","volume":"6","author":"Klezovitch","year":"2004","journal-title":"Cancer Cell."},{"issue":"1","key":"2026093015122681500_cit24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12985-020-01323-z","article-title":"H2 influenza A virus is not pathogenic\nin Tmprss2 knock-out\nmice","volume":"17","author":"Lambertz","year":"2020","journal-title":"Virol. J."},{"issue":"12","key":"2026093015122681500_cit25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 Is Essential\nfor Influenza H1N1 Virus Pathogenesis in Mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog"},{"key":"2026093015122681500_cit26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/MCB.26.3.965-975.2006","article-title":"Phenotypic Analysis\nof Mice Lacking the Tmprss2 -Encoded Protease","volume":"26","author":"Kim","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"2026093015122681500_cit27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021450118","article-title":"Targeting transcriptional\nregulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2","volume":"118","author":"Qiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026093015122681500_cit28","doi-asserted-by":"publisher","first-page":"103255","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat\nmesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases\nand its metabolite GBPA exerts antiviral activity","volume":"65","author":"Hoffmann","year":"2021","journal-title":"EBioMedicine"},{"key":"2026093015122681500_cit29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/labinvest.3700203","article-title":"Camostat mesilate attenuates\npancreatic fibrosis via inhibition of\nmonocytes and pancreatic stellate cells activity","volume":"85","author":"Gibo","year":"2005","journal-title":"Lab. Invest"},{"key":"2026093015122681500_cit30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002392","article-title":"Nafamostat mesilate\nas an anticoagulant during continuous renal replacement therapy in\npatients with high bleeding risk a randomized clinical trial","volume":"94","author":"Choi","year":"2015","journal-title":"Medicine (United States)"},{"key":"2026093015122681500_cit31","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.eclinm.2021.101169","article-title":"Nafamostat in hospitalized\npatients with moderate to\nsevere COVID-19 pneumonia: A randomised Phase II clinical trial","volume":"41","author":"Zhuravel","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026093015122681500_cit32","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.eclinm.2021.100849","article-title":"Efficacy of the TMPRSS2\ninhibitor camostat mesilate in patients hospitalized with Covid-19-a\ndouble-blind randomized controlled trial","volume":"35","author":"Gunst","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026093015122681500_cit33","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.eclinm.2021.100849","article-title":"Efficacy of the TMPRSS2 inhibitor camostat\nmesilate in patients hospitalized\nwith Covid-19-a double-blind randomized controlled trial","volume":"35","author":"Gunst","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2026093015122681500_cit34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12916-022-02518-7","article-title":"A multicenter, double-blind, randomized, parallel-group,\nplacebo-controlled study to evaluate the efficacy and safety of camostat\nmesilate in patients with COVID-19 (CANDLE study)","volume":"20","author":"Kinoshita","year":"2022","journal-title":"BMC Med."},{"key":"2026093015122681500_cit35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1021\/acsmedchemlett.3c00035","article-title":"TMPRSS2 Inhibitor Discovery\nFacilitated through an In Silico and\nBiochemical Screening Platform","volume":"14","author":"Peiffer","year":"2023","journal-title":"ACS Med. Chem.\nLett."},{"issue":"1","key":"2026093015122681500_cit36","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.1038\/s41467-023-42527-5","article-title":"Structure-based discovery of dual pathway inhibitors for SARS-CoV-2\nentry","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"43","key":"2026093015122681500_cit37","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.06.442935","article-title":"A novel\nclass of TMPRSS2 inhibitors potently\nblock SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial\nlung cells","volume":"118","author":"Mahoney","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026093015122681500_cit38","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/acsptsci.0c00106","article-title":"An Enzymatic TMPRSS2\nAssay for Assessment of Clinical Candidates\nand Discovery of Inhibitors as Potential Treatment of COVID-19","volume":"3","author":"Shrimp","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2026093015122681500_cit39","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent\npreclinical efficacy against SARS-CoV-2 by\ntargeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"issue":"11","key":"2026093015122681500_cit40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1691\/ph.2023.3578","article-title":"Repurposing and discovery\nof transmembrane serine protease 2 (TMPRSS2) inhibitors as prophylactic\ntherapies for new coronavirus disease 2019 (COVID-19)","volume":"78","author":"Yang","year":"2023","journal-title":"Pharmazie"},{"key":"2026093015122681500_cit41","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20 - A Free Ultralarge-Scale Chemical Database for Ligand Discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"2026093015122681500_cit42","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","article-title":"Structure and activity of human TMPRSS2 protease\nimplicated in SARS-CoV-2\nactivation","volume":"18","author":"Fraser","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"2026093015122681500_cit43","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1038\/s41467-025-59677-3","article-title":"Structural\nbasis of TMPRSS11D specificity and autocleavage\nactivation","volume":"16","author":"Fraser","year":"2025","journal-title":"Nat. Commun."},{"key":"2026093015122681500_cit44","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","article-title":"ZINC-22\u2013A Free Multi-Billion-Scale Database\nof Tangible Compounds\nfor Ligand Discovery","volume":"63","author":"Tingle","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"2026093015122681500_cit45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s42003-022-03613-4","article-title":"Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in\ncell culture","volume":"5","author":"Wettstein","year":"2022","journal-title":"Commun. Biol."},{"key":"2026093015122681500_cit46","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1021\/acs.biochem.6b00444","article-title":"Protocols for Molecular Modeling with Rosetta3\nand RosettaScripts","volume":"55","author":"Bender","year":"2016","journal-title":"Biochemistry"},{"key":"2026093015122681500_cit47","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","article-title":"A practical guide to\nlarge-scale docking","volume":"16","author":"Bender","year":"2021","journal-title":"Nat.\nProtoc."},{"key":"2026093015122681500_cit48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1107\/S0907444906019949","article-title":"HKL-3000: The integration\nof data reduction and structure solution - From diffraction images\nto an initial model in minutes","volume":"62","author":"Minor","year":"2006","journal-title":"Acta Crystallogr.,\nSect. D: Biol. Crystallogr."},{"key":"2026093015122681500_cit49","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1107\/S0907444904023510","article-title":"REFMAC5 dictionary: Organization of prior chemical\nknowledge and\nguidelines for its use","volume":"60","author":"Vagin","year":"2004","journal-title":"Acta Crystallogr., Sect.\nD: Biol. Crystallogr."},{"key":"2026093015122681500_cit50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data\nfor improved all-atom\nstructure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"2026093015122681500_cit51","article-title":"Three Essential\nResources to Improve\nDifferential Scanning Fluorimetry (DSF) Experiments","author":"Wu","year":"2020","journal-title":"bioRxiv"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c03089","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/19\/19893\/66290432\/acs.jmedchem.4c03089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/19\/19893\/66290432\/acs.jmedchem.4c03089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:49:13Z","timestamp":1790797753000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/19\/19893\/5234574\/Large-Library-Docking-and-Biophysical-Analysis-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":51,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,9,19]]},"published-print":{"date-parts":[[2025,10,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c03089","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2024-v1sc1","asserted-by":"object"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}